Ozaniak, A. et al. (2022) A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade. Journal of Cancer Research and Clinical Oncology, 149, pp. 3789-3801. (doi: 10.1007/s00432-022-04292-8) (PMID:35986756)
Knight, Katrina A., Drami, Ioanna, McMillan, Donald C. ORCID: https://orcid.org/0000-0003-4260-5334, Horgan, Paul G.
ORCID: https://orcid.org/0000-0001-5557-7905, Park, James H.
ORCID: https://orcid.org/0000-0002-6551-2037, Jenkins, John T. and Roxburgh, Campbell S.D.
ORCID: https://orcid.org/0000-0002-2649-6695
(2021)
Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study.
Journal of Cancer Research and Clinical Oncology, 147(11),
pp. 3409-3420.
(doi: 10.1007/s00432-021-03570-1)
(PMID:33710416)
(PMCID:PMC8484095)
Powell, A.G.M.T., Ferguson, J., Al-Mulla, F., Orange, C., McMillan, D.C. ORCID: https://orcid.org/0000-0003-4260-5334, Horgan, P.G.
ORCID: https://orcid.org/0000-0001-5557-7905, Edwards, J.
ORCID: https://orcid.org/0000-0002-7192-6906 and Going, J.J.
(2013)
The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up.
Journal of Cancer Research and Clinical Oncology, 139(12),
pp. 2013-2020.
(doi: 10.1007/s00432-013-1521-2)
Powell, A.G.M.T., Horgan, P.G. ORCID: https://orcid.org/0000-0001-5557-7905 and Edwards, J.
ORCID: https://orcid.org/0000-0002-7192-6906
(2012)
The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?
Journal of Cancer Research and Clinical Oncology, 138(5),
pp. 723-728.
(doi: 10.1007/s00432-012-1192-4)
Elsberger, B., Paravasthu, D.M., Tovey, S.M. and Edwards, J. ORCID: https://orcid.org/0000-0002-7192-6906
(2012)
Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment.
Journal of Cancer Research and Clinical Oncology, 138(2),
pp. 327-332.
(doi: 10.1007/s00432-011-1096-8)
Cassidy, James, Saltz, Leonard B., Giantonio, Bruce J., Kabbinavar, Fairooz F., Hurwitz, Herbert I. and Rohr, Ulrich-Peter (2010) Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. Journal of Cancer Research and Clinical Oncology, 136(5), pp. 737-743. (doi: 10.1007/s00432-009-0712-3)
Davison, A.J. ORCID: https://orcid.org/0000-0002-4991-9128, Sauerbier, W., Dolan, A., Addison, C. and McKinnell, R.G.
(1999)
Genomic studies of the Lucke tumor herpesvirus (RaHV-1).
Journal of Cancer Research and Clinical Oncology, 125(3-4),
pp. 232-238.
(doi: 10.1007/s004320050268)
Fulton, R., Plumb, M., Shield, L. and Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279
(1990)
Investigation of cellular specificity associated with the enhancer and promoter regions of FeLV LTRs.
Journal of Cancer Research and Clinical Oncology, 116,
p. 1065.